WO2021208280A1 - Application of dried fly larva in preparation of drugs for preventing and treating breast hyperplasia - Google Patents
Application of dried fly larva in preparation of drugs for preventing and treating breast hyperplasia Download PDFInfo
- Publication number
- WO2021208280A1 WO2021208280A1 PCT/CN2020/102074 CN2020102074W WO2021208280A1 WO 2021208280 A1 WO2021208280 A1 WO 2021208280A1 CN 2020102074 W CN2020102074 W CN 2020102074W WO 2021208280 A1 WO2021208280 A1 WO 2021208280A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chong
- group
- hyperplasia
- application
- grain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the invention belongs to the technical field of medicine, and particularly relates to the application of the worms in the preparation of drugs for preventing and treating breast hyperplasia.
- Hyperplasia of mammary glands is a common chronic proliferative disease of mammary gland structure disorder in women, which can cause abnormalities in the structure and tissue morphology of the mammary glands, manifested by different degrees of hyperplasia and incomplete involution of the mammary glands and interstitium. .
- the incidence of breast hyperplasia in women’s breast tissue is 30% to 60%. It is a common disease in women. It has a high incidence. With the deepening of research on it, scholars have proposed that breast hyperplasia is related to breast cancer. , And the rate of malignant transformation is gradually increasing. In recent years, attention to women's health, that is, the prevention and treatment of breast hyperplasia, has become a hot spot in the medical field.
- the dried larva (maggot) of the insect Diptera Chrysomya megacephala (also known as Chrysomya megacephala) and its close relatives (such as the housefly Musca domestica ) is a traditional Chinese medicine blindly called “five worms.” , Also known as Water Fairy and Luo Fairy, commonly known as “maggots”.
- the grain insects are cold in nature and non-toxic, enter the spleen and stomach meridian. After drying and grinding, they can be applied and applied for external use. It can treat ecthyma, lip furuncle and carbuncle and other infectious surgery disease.
- Wu Gu Chong was first published in the 40th volume of the Insect Department of Compendium of Materia Medica. It has the functions of clearing heat and eliminating stagnation, and has the pharmacological effects of treating malnutrition, abdominal distension and malnutrition.
- the purpose of the present invention is to provide a new use of grain insects for the prevention and treatment of mammary gland hyperplasia.
- the grain insect extract is an alcohol-water double extract of grain insect.
- the invention also provides a medicine for preventing and treating hyperplasia of mammary glands.
- the medicament may also contain pharmaceutically acceptable conventional auxiliary materials, such as disintegrants, lubricants, emulsifiers, adhesives, etc., which are directly or indirectly added to the pharmacy by conventional methods of traditional Chinese medicine preparations through conventional processing. Acceptable excipients.
- pharmaceutically acceptable conventional auxiliary materials such as disintegrants, lubricants, emulsifiers, adhesives, etc.
- the clinical preparation of the drug is granules, capsules, tablets, pills or oral liquids, which are easy to take, highly targeted, and have obvious curative effects.
- Figure 1 is a bar graph of the weight changes of female rats before modeling, after modeling, and after administration;
- Figure 2 is a bar graph showing changes in the height of the nipple of SD female rats before modeling, after modeling, and after administration;
- Figure 3 is a bar graph showing changes in the nipple diameter of SD female rats before modeling, after modeling, and after administration;
- Figure 4 is a bar graph showing the effect of Wu Gu Chong on the uterine index of SD rats
- Figure 5 is a bar graph showing the effect of Wu Gu Chong on the levels of serum estradiol (E2) and prolactin (PRL) in rats.
- the present invention also establishes a mammary hyperplasia rat model through estradiol benzoate combined with progesterone, and takes the clinical medication Rupixiao tablet as a positive drug to observe the effect of the double extract of the alcoholic water extract of Cephalocarpus on the height and diameter of the nipple and the mammary gland tissue of the rat with hyperplasia of mammary glands.
- Rupixiao tablet as a positive drug to observe the effect of the double extract of the alcoholic water extract of Cephalocarpus on the height and diameter of the nipple and the mammary gland tissue of the rat with hyperplasia of mammary glands.
- it is used to guide the clinical medication of Wu Gu Chong.
- Estradiol benzoate injection (Ningbo Second Hormone Factory, batch number: 110252511); Progesterone injection (Ningbo Second Hormone Factory, batch number: 110251670); Rupixiao tablets (Liaoning Shangyao Good Nurse Pharmaceutical Group Co., Ltd. , Batch number: 190413); grain insects (batch number: 20191013); physiological saline (Hangzhou Minsheng Pharmaceutical Co., Ltd., batch number: A1901152)
- 65 SD rats were randomly divided into 6 groups, namely the blank control group (group A), the HMG model group (group B), the positive drug Rupixiao tablet (group C), the Wuguchong high-dose group (group D), Wu Gu Chong medium dose group (E group), Wu Gu Chong low dose group (F group).
- the modeling method is as follows: rats in the blank group were injected intramuscularly with normal saline injection 0.25mL/(Kg ⁇ d) in the right lower limbs for a total of 30 days; SD rats in the non-blank group were injected with estradiol benzoate intramuscularly in the lower limbs at a dose of 0.5 mg/(Kg ⁇ d), after 25 days of continuous injection, each rat was changed to intramuscular injection of progesterone at a dose of 5.0 mg/(Kg ⁇ d) for a total of 5 days [11,12,13] . Thirty days after the establishment of the model, the rat's nipples were straight, firm, red and enlarged. Randomly select 5 rats in the non-blank group, take a second pair of breast tissue for tissue section, HE staining, and use histological "gold standard" to determine whether a rat model of mammary gland hyperplasia is established.
- the dosage and method are as follows: Group A and Group B were given distilled water, 1 mL/100g, once a day; Group C was given Rupixiao tablet powder by intragastric administration Aqueous solution prepared with distilled water, the dose is 960mg/(Kg ⁇ d), 1 mL/100g, once a day; Group D is the high-dose group of the high-dose alcohol-water double-extract of Cephalosporium distilled by gavage, 1620mg/Kg, 1 mL/100g, once a day, the medium dose group of E group, 810mg/Kg, 1 mL/100g, once a day, group F, low-dose group, 405mg/Kg, 1 mL/100g, once a day, continuous intragastric administration for 27 days.
- Organ index organ mass (g)/weight (g)
- the present invention establishes a rat model of mammary gland hyperplasia through estradiol benzoate combined with progesterone.
- the clinical drug Rupixiao tablet is used as a positive drug to observe the effect of the alcohol-water double extract of arachnids on the nipple height and diameter, mammary gland tissue and The effect of estradiol and prolactin on hormone levels.
- This experiment is divided into 3 stages, namely, before modeling of breast hyperplasia, after modeling, and after intragastric administration.
- the initial body weight of rats in each group had no significant difference ( P >0.05).
- the weight of rats in the normal group continued to increase during the modeling period.
- the weight of the rest of the modeled female rats was significantly reduced ( P ⁇ 0.01), indicating that the injection of estradiol benzoate and the Progesterone estrogen can inhibit the growth of SD female rats, and its modeling is more successful from the appearance observation.
- the body weight of the female rats in the other groups was significantly reduced ( P ⁇ 0.01).
- the initial nipple height and diameter of rats in each group had no significant difference ( P >0.1).
- the nipple height and diameter of the other groups were significantly increased ( P ⁇ 0.01), indicating that injection of estradiol benzoate and progesterone estrogen can promote the growth of SD female rats' nipple.
- hypothalamic-pituitary-gonadal axis is one of the components of the nerve structure and plays an important role in maintaining the stability of the internal environment and the normal physiological functions of the body [14] .
- Abnormal secretion of sex hormones can lead to many diseases, such as hyperprolactinemia. , Breast hyperplasia, uterine fibroids, etc.
- the levels of various sex hormones jointly regulate breast tissue, among which elevated levels of prolactin (PRL) are considered to be an important factor in causing breast hyperplasia [15,16] , and progesterone (PROG) levels promote acinar tissue and breast lobules , Estradiol (E 2 ) increased levels inhibited the growth of fibrous tissue around ducts and mammary ducts.
- Sex hormone disorders often occur in breast hyperplasia models, which can regulate the balance of the hypothalamus-pituitary-gonadal axis to regulate the levels of E 2 , PROG, and PRL, restore ovarian function, and eliminate lobular hyperplasia and acinar hyperplasia [5] .
- the estradiol level of the model group was significantly increased ( P ⁇ 0.01), and compared with the model group, the estradiol level of the other administration groups was significantly reduced ( P ⁇ 0.01) ), compared with the positive drug group, the Wu Gu Chong medium dose group was significantly higher ( P ⁇ 0.05), and there was no significant difference between the high and low doses of Wu Gu Chong ( P > 0.05). It shows that the high-dose and low-dose groups of Wu Gu Chong can significantly reduce the level of estradiol hormone in rats with hyperplasia of mammary glands.
- the worm can regulate the disordered hormones in rats with mammary gland hyperplasia, and its main components have the function of balancing estrogen, and have protective and repairing effects on mammary gland hyperplasia.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本发明属于医药技术领域,特别涉及五谷虫在制备预防和治疗乳腺增生药物中的应用。The invention belongs to the technical field of medicine, and particularly relates to the application of the worms in the preparation of drugs for preventing and treating breast hyperplasia.
乳腺增生症(hyperplasia of mammary glands,HMG)是女性常见的乳腺结构紊乱的慢性增生性疾病,会造成乳腺结构及组织形态上的异常,表现为乳腺腺体和间质不同程度的增生与复旧不全。乳腺增生在女性乳房组织中发病率为 30%~60% ,是女性的常见病,它发病率较高,随着对其研究的深入,已有学者提出乳腺增生与乳腺癌有一定的相关性,且恶变率正逐步上升。近年来关注女性健康,即重视乳腺增生的预防与治疗已然成为医学界热点。Hyperplasia of mammary glands (HMG) is a common chronic proliferative disease of mammary gland structure disorder in women, which can cause abnormalities in the structure and tissue morphology of the mammary glands, manifested by different degrees of hyperplasia and incomplete involution of the mammary glands and interstitium. . The incidence of breast hyperplasia in women’s breast tissue is 30% to 60%. It is a common disease in women. It has a high incidence. With the deepening of research on it, scholars have proposed that breast hyperplasia is related to breast cancer. , And the rate of malignant transformation is gradually increasing. In recent years, attention to women's health, that is, the prevention and treatment of breast hyperplasia, has become a hot spot in the medical field.
目前临床上对乳腺增生病还没有一种适用性广且疗效肯定的治疗药物或方案。西医对于HMG的治疗多采用激素类制剂如雄激素、黄体酮、三苯氧胺、溴隐亭、达那唑,还有碘制剂等。但因其疗效存在一定的副作用且容易复发,许多学者呈反对态度,患者的依从性也相对较差。乳腺增生病是中医治疗的优势病种,近年来中医药疗法治疗乳腺增生症的疗效得到越来越多的医生及患者的肯定,其中中医外治法具有操作简便、疗效显著、直达病所、毒副作用小等显著优势而成为一个重要的治疗方法。中药能有效治疗乳腺增生,且毒副作用小。At present, there is no clinically applicable drug or program for the treatment of hyperplasia of mammary glands. Western medicine usually uses hormone preparations such as androgen, progesterone, tamoxifen, bromocriptine, danazol, and iodine preparations for the treatment of HMG. However, due to its curative effect has certain side effects and is prone to relapse, many scholars are opposed to it, and the compliance of patients is relatively poor. Hyperplasia of mammary glands is the dominant disease in traditional Chinese medicine. In recent years, the curative effect of traditional Chinese medicine in the treatment of hyperplasia of mammary glands has been affirmed by more and more doctors and patients. It has become an important treatment method due to its significant advantages such as small side effects. Traditional Chinese medicine can effectively treat breast hyperplasia with little side effects.
昆虫双翅目大头金蝇( Chrysomya megacephala,又名大头丽蝇、东方厕蝇)及其近缘昆虫(如家蝇 Musca domestica)的干燥幼虫(蝇蛆)是一味传统中药,名曰“五谷虫”,又名水仙子、罗仙子,俗名“蛆”。《本草求源》、《本草便读》记载,五谷虫性寒、无毒,入脾、胃经,经干燥研磨后,供搽敷外用,能治疗臁疮、唇疔和痈疽等感染性外科疾病。五谷虫始载于《本草纲目》虫部第四十卷,具有清热、消滞的作用,治疳积腹胀、疳疮等的药理作用。 The dried larva (maggot) of the insect Diptera Chrysomya megacephala (also known as Chrysomya megacephala) and its close relatives (such as the housefly Musca domestica ) is a traditional Chinese medicine blindly called "five worms." , Also known as Water Fairy and Luo Fairy, commonly known as "maggots". According to the records of "Materia Medica Seeking Source" and "Materia Medica Biandu", the grain insects are cold in nature and non-toxic, enter the spleen and stomach meridian. After drying and grinding, they can be applied and applied for external use. It can treat ecthyma, lip furuncle and carbuncle and other infectious surgery disease. Wu Gu Chong was first published in the 40th volume of the Insect Department of Compendium of Materia Medica. It has the functions of clearing heat and eliminating stagnation, and has the pharmacological effects of treating malnutrition, abdominal distension and malnutrition.
目前五谷虫治疗乳腺增生尚未有研究报道。 At present, there is no research report on Wu Gu Chong's treatment of breast hyperplasia.
本发明的目的是提供一种五谷虫的新用途,用于预防和治疗乳腺增生。The purpose of the present invention is to provide a new use of grain insects for the prevention and treatment of mammary gland hyperplasia.
更具体地,提供五谷虫在制备预防和治疗乳腺增生药物中的应用。More specifically, it provides the application of Wu Gu Chong in the preparation of medicines for preventing and treating breast hyperplasia.
更具体地说,是五谷虫在降低乳腺增生催乳素激素水平药物中的应用。More specifically, it is the application of Wu Gu Chong in the medicine for reducing the prolactin hormone level of mammary gland hyperplasia.
作为优选,五谷虫提取物在在制备预防和治疗乳腺增生药物中的应用。As a preference, the use of the extracts of Chinese grain insects in the preparation of medicines for preventing and treating breast hyperplasia.
更优选地,五谷虫提取物为五谷虫醇水双提物。More preferably, the grain insect extract is an alcohol-water double extract of grain insect.
五谷虫在治疗由于外源雌激素水平增高所引起的子宫增厚药物中的应用。Application of Wu Gu Chong in the treatment of uterine thickening drugs caused by increased levels of exogenous estrogen.
五谷虫在治疗由于外源雌激素水平增高所引起的乳头结节药物中的应用。Application of Wu Gu Chong in the treatment of nipple nodules caused by increased levels of exogenous estrogen.
本发明还提供一种预防和治疗乳腺增生的药物,其成分中含有五谷虫或五谷虫醇水双提物。The invention also provides a medicine for preventing and treating hyperplasia of mammary glands.
作为优选,所述药物中还可以含有药学上可接受的常规的辅料,如崩解剂、润滑剂、乳化剂、粘合剂等,以常规中药制剂方法,经常规加工直接或间接的加入药学上的可接受的辅料。Preferably, the medicament may also contain pharmaceutically acceptable conventional auxiliary materials, such as disintegrants, lubricants, emulsifiers, adhesives, etc., which are directly or indirectly added to the pharmacy by conventional methods of traditional Chinese medicine preparations through conventional processing. Acceptable excipients.
优选的,所述药物的临床制剂为颗粒剂、胶囊剂、片剂、丸剂或口服液,易于服用,针对性强,疗效明显。Preferably, the clinical preparation of the drug is granules, capsules, tablets, pills or oral liquids, which are easy to take, highly targeted, and have obvious curative effects.
本发明具有如下的有益效果:The present invention has the following beneficial effects:
提供五谷虫的新用途,扩展了五谷虫的使用范围;Provide new uses of grain insects and expand the scope of use of grain insects;
为乳腺增生提供了新的预防和治疗思路;Provides new prevention and treatment ideas for breast hyperplasia;
采用五谷虫对乳腺增生进行治疗,疗效显著、直达病所、毒副作用小。The treatment of mammary gland hyperplasia with Wu Gu Chong has obvious curative effect, direct access to the disease, and small side effects.
附图1为雌性大鼠造模前、造模后与给药后体重变化柱形图;Figure 1 is a bar graph of the weight changes of female rats before modeling, after modeling, and after administration;
附图2为SD雌性大鼠造模前、造模后与给药后乳头高度的变化柱形图;Figure 2 is a bar graph showing changes in the height of the nipple of SD female rats before modeling, after modeling, and after administration;
附图3为 SD雌性大鼠造模前、造模后与给药后乳头直径的变化柱形图;Figure 3 is a bar graph showing changes in the nipple diameter of SD female rats before modeling, after modeling, and after administration;
附图4为五谷虫对SD大鼠子宫指数的影响柱形图;Figure 4 is a bar graph showing the effect of Wu Gu Chong on the uterine index of SD rats;
附图5为五谷虫对大鼠血清雌二醇(E2)与催乳素(PRL)水平的影响柱形图。Figure 5 is a bar graph showing the effect of Wu Gu Chong on the levels of serum estradiol (E2) and prolactin (PRL) in rats.
实施例1Example 1
浙江省长兴县林城镇患者周某,48岁,女,曾行乳腺小叶增生切除术,现双乳胀大如哺乳期间妇女的乳房,痛势剧烈,手不可碰,经朋友推荐,来中医馆购买五谷虫粉末口服治疗,每天二次,每次3克,服用三个月后,肿胀的乳房渐渐缩小,疼痛明显缓解,经连续服用6个月,目前状况越来越好。Zhou, a 48-year-old female patient from Lincheng Township, Changxing County, Zhejiang Province, had undergone breast lobular hyperplasia resection, and her breasts were swollen like a woman's breasts during breastfeeding. The pain was severe and her hands could not be touched. On the recommendation of a friend, she came to the Chinese Medicine Clinic. Purchased Wu Gu insect powder for oral treatment, twice a day, 3 grams each time. After taking it for three months, the swollen breast gradually shrinks and the pain is relieved. After taking it continuously for 6 months, the current condition is getting better and better.
下面结合具体实施方式对本发明的发明内容作进一步的详细描述。应理解,本发明的实施例只用于说明本发明而非限制本发明,在不脱离本发明技术思想的情况下,根据本领域普通技术知识和惯用手段,做出的各种替换和变更,均应包括在本发明的范围内。The content of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the embodiments of the present invention are only used to illustrate the present invention but not to limit the present invention. Without departing from the technical ideas of the present invention, various substitutions and changes made based on common technical knowledge and conventional means in the field, All should be included in the scope of the present invention.
实施例2Example 2
浙江省长兴县泗安镇患者,吴某,女,41岁,因月经期间左乳胀痛,去县人民医院检查,超声检查显示左乳2点钟处可见约7*9mm的低回声,在中医馆购买了五谷虫粉末口服治疗,每天二次,每次3克,次月月经来时,疼痛感减轻,连续服用70天后,超声检查结果显示,左乳二点钟处的结节缩小为3.5*4mm。A patient from Si’an Town, Changxing County, Zhejiang Province, Wu Mou, female, 41 years old, went to the County People’s Hospital for examination due to left breast swelling and pain during menstruation. The Chinese Medicine Museum purchased the oral treatment of Wu Gu insect powder, twice a day, 3 grams each time. When the menstruation came in the next month, the pain was relieved. After 70 days of continuous use, the ultrasound examination results showed that the nodules at 2 o'clock on the left breast were reduced to 3.5*4mm.
实施例3Example 3
浙江省湖州市南浔区患者,陈某,女,39岁,双侧乳腺增生已有数年,影响腋下淋巴管,双侧出现副乳,平时胸部胀痛,月经期前疼痛更甚,经朋友推荐,在中医馆购买了五谷虫粉末口服治疗,每天二次,每次2.5克,服用一个月后疼痛明显减轻,四个月后副乳消失。Patient in Nanxun District, Huzhou City, Zhejiang Province, Chen, female, 39 years old, bilateral breast hyperplasia has been for several years, affecting the lymphatic vessels under the arm, bilateral accessory breasts, usually chest pain, more pain before menstruation, menstrual friend It is recommended that I bought the five-grain insect powder for oral treatment at the Chinese Medicine Museum, twice a day, 2.5 grams each time. After taking it for one month, the pain was significantly reduced, and the accessory milk disappeared after four months.
实施例4Example 4
浙江省长兴县虹星桥镇患者,夏某,女,46岁,自查双乳有大小不一肿块数枚,月经前疼痛感强烈。经朋友推荐,到中医馆就诊,购买五谷虫粉末治疗,每天6克,分二次服用,连续服用二个月后疼痛感逐渐消失,四个月后经超声检查双乳未发现明显的结节肿块。A patient from Hongxingqiao Town, Changxing County, Zhejiang Province, Xia, female, 46 years old, self-examined several lumps of different sizes in both breasts, and felt intense pain before menstruation. After a friend’s recommendation, I went to the Chinese Medicine Museum and purchased the five-grain insect powder for treatment, 6 grams a day, divided into two doses. After two months of continuous use, the pain gradually disappeared. Four months later, no obvious nodules were found in the breasts after ultrasound examination. Lumps.
实施例5Example 5
浙江省湖州市患者陈某,女,35岁,于2018年6月份体检时发现,左乳11点钟处可见6*5mm的低回声,右乳10点钟处可见约4*3mm的低回声。双侧腋下扫查,均可见数个淋巴结回声,左侧较大的14mmx4mm、右侧较大的13mmx4mm,服用五谷虫每天二次,每次2.5克,连续服用70天后乳房胀痛感明显好转,服用6个月后再次超声检查,左乳11点钟处有3*2.6mm低回声结节,右乳结节消失,未见明显肿大淋巴结回声。A 35-year-old female patient from Huzhou City, Zhejiang Province, Chen, found during a physical examination in June 2018 that a 6*5mm hypoechoic echo was seen at 11 o'clock in the left breast and a 4*3mm hypoechoic echo was seen at 10 o'clock in the right breast. . On both sides of the axillary scan, several lymph node echoes can be seen, the larger 14mmx4mm on the left and the larger 13mmx4mm on the right. Take Wu Gu Chong twice a day, 2.5 grams each time. After 70 days of continuous use, the breast tenderness and pain will be significantly improved. After taking it for 6 months, the ultrasound examination again showed that there was a 3*2.6mm hypoechoic nodule at 11 o'clock in the left breast, and the right breast nodule disappeared, and there was no obvious swollen lymph node echo.
本发明还通过苯甲酸雌二醇联合黄体酮建立乳腺增生大鼠模型,以临床用药乳癖消片为阳性药,观察五谷虫醇水双提物对乳腺增生大鼠乳头高度与直径,乳腺组织以及激素水平雌二醇与催乳素的影响,用以指导五谷虫临床用药。The present invention also establishes a mammary hyperplasia rat model through estradiol benzoate combined with progesterone, and takes the clinical medication Rupixiao tablet as a positive drug to observe the effect of the double extract of the alcoholic water extract of Cephalocarpus on the height and diameter of the nipple and the mammary gland tissue of the rat with hyperplasia of mammary glands. As well as the influence of hormone levels of estradiol and prolactin, it is used to guide the clinical medication of Wu Gu Chong.
1 材料与方法1 Materials and methods
1.1 实验动物1.1 Experimental animals
SPF 级雌性 SD(Sprage-Dawley)大鼠65只,未孕,体重 180~200g,饲养于浙江中医药大学实验动物中心;实验室室温控制在 (22±3) ℃,相对湿度 45%~55%,动物自由饮水,适应性饲养 1 周后开始实验。65 SPF female SD (Sprage-Dawley) rats, non-pregnant, weighing 180~200g, were raised in the Experimental Animal Center of Zhejiang University of Traditional Chinese Medicine; the laboratory room temperature was controlled at (22±3) ℃, and the relative humidity was 45%~55 %, the animals drink freely, and start the experiment after 1 week of adaptive feeding.
1.2 试剂及药物1.2 Reagents and drugs
苯甲酸雌二醇注射液 (宁波第二激素厂,批号:110252511);黄体酮注射液(宁波第二激素厂,批号:110251670);乳癖消片(辽宁上药好护士药业集团有限公司,批号:190413);五谷虫(批号:20191013);生理盐水(杭州民生药业有限公司,批号:A1901152)Estradiol benzoate injection (Ningbo Second Hormone Factory, batch number: 110252511); Progesterone injection (Ningbo Second Hormone Factory, batch number: 110251670); Rupixiao tablets (Liaoning Shangyao Good Nurse Pharmaceutical Group Co., Ltd. , Batch number: 190413); grain insects (batch number: 20191013); physiological saline (Hangzhou Minsheng Pharmaceutical Co., Ltd., batch number: A1901152)
1.3 实验分组及大鼠HMG模型的建立1.3 Experimental grouping and establishment of rat HMG model
65只SD大鼠随机分为6组,分别为空白对照组(A组)、HMG模型组(B组)、阳性药乳癖消片(C组)、五谷虫高剂量组(D组)、五谷虫中剂量组(E组)、五谷虫低剂量组(F组)。建模方法如下:空白组大鼠右下肢肌内注射生理盐水注射液0.25mL/(Kg·d),共注射30d;非空白组SD大鼠下肢肌内注射苯甲酸雌二醇,注射剂量0.5mg/(Kg·d),连续注射25d后,改为每只大鼠肌内注射黄体酮,注射剂量为5.0mg/(Kg·d),共注射5d [11,12,13]。建立模型30d后,大鼠乳头直挺、坚实、变红、增大。随机抽取非空白组中的5只大鼠,取第二对乳腺组织进行组织切片,HE染色,利用组织学“金标准”判断是否建成大鼠乳腺增生模型。 65 SD rats were randomly divided into 6 groups, namely the blank control group (group A), the HMG model group (group B), the positive drug Rupixiao tablet (group C), the Wuguchong high-dose group (group D), Wu Gu Chong medium dose group (E group), Wu Gu Chong low dose group (F group). The modeling method is as follows: rats in the blank group were injected intramuscularly with normal saline injection 0.25mL/(Kg·d) in the right lower limbs for a total of 30 days; SD rats in the non-blank group were injected with estradiol benzoate intramuscularly in the lower limbs at a dose of 0.5 mg/(Kg·d), after 25 days of continuous injection, each rat was changed to intramuscular injection of progesterone at a dose of 5.0 mg/(Kg·d) for a total of 5 days [11,12,13] . Thirty days after the establishment of the model, the rat's nipples were straight, firm, red and enlarged. Randomly select 5 rats in the non-blank group, take a second pair of breast tissue for tissue section, HE staining, and use histological "gold standard" to determine whether a rat model of mammary gland hyperplasia is established.
1.4 分组剂量及给药1.4 Group dosage and administration
大鼠 HMG模型建立成功后,按照分组进行给药治疗,剂量及方法如下:A组和B组灌胃给予蒸馏水,1 mL/100g,每日1次;C组灌胃给予乳癖消片粉末加蒸馏水配成的水溶液,剂量960mg/(Kg·d),1 mL/100g,每日1次;D组灌胃五谷虫醇水双提液高剂量组,1620mg/Kg,1 mL/100g,每日1次,E组灌胃五谷虫醇水双提液中剂量组,810mg/Kg,1 mL/100g,每日1次,F组灌胃五谷虫醇水双提液低剂量组,405mg/Kg,1 mL/100g,每日1次,连续灌胃给药27 d。After successful establishment of the rat HMG model, the rats were administered and treated according to the groups. The dosage and method are as follows: Group A and Group B were given distilled water, 1 mL/100g, once a day; Group C was given Rupixiao tablet powder by intragastric administration Aqueous solution prepared with distilled water, the dose is 960mg/(Kg·d), 1 mL/100g, once a day; Group D is the high-dose group of the high-dose alcohol-water double-extract of Cephalosporium distilled by gavage, 1620mg/Kg, 1 mL/100g, once a day, the medium dose group of E group, 810mg/Kg, 1 mL/100g, once a day, group F, low-dose group, 405mg/Kg, 1 mL/100g, once a day, continuous intragastric administration for 27 days.
1.5 观察指标和方法1.5 Observation indicators and methods
1.5.1 乳头直径、高度测量 使用游标卡尺精确测量大鼠初始、建模、治疗后每个时期的第2对乳房乳头直径及高度并拍照。1.5.1 Measurement of nipple diameter and height Use vernier calipers to accurately measure the diameter and height of the second pair of breast nipple in each period after the initial, modeling, and treatment of the rat and take pictures.
1.5.2 脏器指数的测定 末次灌胃后禁食12h后处死大鼠,分别摘取每只大鼠的子宫,利用分析电子天平精密称重质量,计算脏器指数。1.5.2 Determination of organ index After the last gastric gavage, the rats were sacrificed after 12 hours of fasting. The uterus of each rat was taken out, and the mass was precisely weighed with an analytical electronic balance to calculate the organ index.
脏器指数=脏器质量(g)/体重(g)Organ index = organ mass (g)/weight (g)
1.5.3激素的测定 末次灌胃后禁食12h后,利用3% 戊巴比妥对大鼠进行麻醉,心脏采血,血液静置1h,3000r/min离心15min,收集并分装血清至1.5mL EP管,-20℃保存,用于检测雌二醇(E 2),催乳素(PRL)含量,测定方法按照试剂盒说明书进行。 1.5.3 Determination of hormones After 12 hours of fasting after the last gavage, the rats were anesthetized with 3% pentobarbital, blood was collected from the heart, the blood was left for 1 hour, centrifuged at 3000 r/min for 15 minutes, and the serum was collected and aliquoted to 1.5 mL EP tube, stored at -20°C, is used to detect estradiol (E 2 ) and prolactin (PRL) content. The determination method is carried out in accordance with the kit instructions.
1.6 统计学方法 1.6 Statistical methods
采用 SPSS17. 0 软件处理实验数据。多组间单因素比较先用单因素分析其正态分布,后以 LSD 法进行统计。 P < 0. 05 为差异有统计学意义。 Use SPSS17.0 software to process the experimental data. Single factor comparisons among multiple groups were first used to analyze the normal distribution of the single factor, and then statistically performed by the LSD method. P <0.05 is considered statistically significant.
2. 结果与分析2. Results and analysis
2.1 五谷虫对乳腺增生大鼠体重的影响2.1 The effect of Wu Gu Chong on the body weight of rats with hyperplasia of mammary glands
由表1和图1可知,各组大鼠的初始体重无显著差异( P>0.05)。正常组大鼠在试验期间体重持续增长,经过30d造模后,与正常对照组相比,其余各造模雌性大鼠体重均显著降低( P<0.01),说明注射苯甲酸雌二醇与黄体酮雌激素会抑制SD雌性大鼠的生长。经过灌胃给药27d,与正常对照组相比,其余各组雌性大鼠体重均显著降低( P<0.01),与模型组相比,其余各给药组雌性大鼠体重均无显著差异( P>0.1),说明阳性药乳癖消片与五谷虫高、中、低剂量不能缓解由于外源高水平雌激素所引起的雌性大鼠生长抑制的现象。 It can be seen from Table 1 and Figure 1 that there was no significant difference in the initial body weight of rats in each group ( P >0.05). The weight of rats in the normal group continued to increase during the experiment. After 30 days of modeling, compared with the normal control group, the weight of the other modeled female rats was significantly reduced ( P <0.01), indicating that estradiol benzoate and corpus luteum were injected Ketoestrogens inhibit the growth of SD female rats. After intragastric administration for 27 days, compared with the normal control group, the body weight of the female rats in the other groups was significantly reduced ( P <0.01). Compared with the model group, there was no significant difference in the body weight of the female rats in the other treatment groups ( P >0.1), indicating that the high, medium and low doses of the positive drug Rupixiao Tablets and Wu Gu Chong can not alleviate the growth inhibition of female rats caused by exogenous high levels of estrogen.
2.2 五谷虫对大鼠乳头高度与直径的影响2.2 The effect of Wu Gu insect on the height and diameter of the rat's nipple
由表2与图2可知,各组大鼠的初始乳头高度无显著差异( P>0.1)。造模30d后,与空白对照组相比,其余各组乳头高度显著增高( P<0.01),说明注射苯甲酸雌二醇与黄体酮雌激素会促进SD雌性大鼠乳头的生长。灌胃给药27d后,与正常对照组相比,模型组乳头高度显著增高( P<0.01),其余各给药组乳头高度显著下降( P<0.01);阳性药组、五谷虫高、中、低剂量之间无显著差异( P>0.05)。表明五谷虫可治疗由于外源雌激素水平增高所引起的乳头增高现象,药效与阳性药相当。 It can be seen from Table 2 and Figure 2 that there was no significant difference in the initial nipple height of rats in each group ( P >0.1). Thirty days after modeling, compared with the blank control group, the nipple height of the other groups increased significantly ( P <0.01), indicating that injection of estradiol benzoate and progesterone estrogen can promote the growth of SD female rats' nipple. After 27 days of intragastric administration, compared with the normal control group, the nipple height of the model group was significantly increased ( P <0.01), and the nipple height of the other administration groups was significantly decreased ( P <0.01); the positive drug group, Wu Gu Chong high, medium There was no significant difference between the low doses ( P >0.05). It shows that Wu Gu Chong can treat the increase of nipples caused by the increase of exogenous estrogen levels, and the efficacy is equivalent to that of positive drugs.
由表3与图3可知,各组大鼠的初始乳头直径无显著差异( P>0.1)。造模30d后,与空白对照组相比,其余各组乳头高度显著增高( P<0.01),说明注射苯甲酸雌二醇与黄体酮雌激素会促进SD雌性大鼠乳头的生长。灌胃给药27d后,与正常对照组相比,模型组乳头直径显著增高( P<0.01),其余各给药组乳头高度显著下降( P<0.01);阳性药组、五谷虫高、中、低剂量之间无显著差异( P>0.05)。表明五谷虫可治疗由于外源雌激素水平增高所引起的乳头增大的现象,药效与阳性药相当。 It can be seen from Table 3 and Figure 3 that there was no significant difference in the initial nipple diameter of rats in each group ( P >0.1). Thirty days after modeling, compared with the blank control group, the nipple height of the other groups increased significantly ( P <0.01), indicating that injection of estradiol benzoate and progesterone estrogen can promote the growth of SD female rats' nipple. After 27 days of intragastric administration, compared with the normal control group, the nipple diameter of the model group was significantly increased ( P <0.01), and the nipple height of the other administration groups was significantly decreased ( P <0.01); the positive drug group, Wu Gu Chong high, medium There was no significant difference between the low doses ( P >0.05). It shows that Wu Gu Chong can treat the phenomenon of nipple enlargement caused by the increase of exogenous estrogen level, and the efficacy is equivalent to that of the positive medicine.
2.3 五谷虫对子宫指数的影响2.3 The effect of Wu Gu Chong on the uterine index
雌激素过高会使子宫壁增厚,结果显示,与正常对照组相比,模型组子宫指数显著升高( P<0.01),与模型组相比,各给药组子宫指数显著下降( P<0.01);阳性药组、五谷虫高、中、低剂量之间无显著差异( P>0.05)。表明五谷虫可治疗由于外源雌激素水平增高所引起的子宫增厚的现象,药效与阳性药相当。 Excessive estrogen will thicken the uterine wall. The results show that compared with the normal control group, the uterine index of the model group was significantly increased ( P <0.01), and compared with the model group, the uterine index of each administration group was significantly decreased ( P <0.01); there was no significant difference between the positive drug group and the high, medium and low doses of Wu Gu Chong ( P > 0.05). It shows that Wu Gu Chong can treat the thickening of the uterus caused by the increase of exogenous estrogen levels, and the efficacy is equivalent to that of the positive medicine.
2.4 五谷虫对大鼠血清雌二醇(E2)与催乳素(PRL)水平的影响2.4 The effect of Wu Gu Chong on serum estradiol (E2) and prolactin (PRL) levels in rats
由表5与图5对大鼠雌二醇水平分析可知,与正常对照组相比,模型组雌二醇水平显著升高( P<0.01),与模型组相比,其余各给药组雌二醇水平显著降低( P<0.01),与阳性药组相比,五谷虫中剂量组显著升高( P<0.05),五谷虫高剂量与低剂量无显著差异( P>0.05)。结果表明,五谷虫高剂量、低剂量组可以显著降低乳腺增生大鼠雌二醇激素水平,药效与阳性药相当。 From Table 5 and Figure 5, the analysis of estradiol levels in rats shows that compared with the normal control group, the estradiol level of the model group was significantly increased ( P <0.01). Compared with the model group, the estradiol level of the other administration groups The level of diol was significantly reduced ( P <0.01). Compared with the positive drug group, the medium-dose group of Wu Gu Chong was significantly increased (P <0.05), and there was no significant difference between the high-dose and low-dose Wu Gu Chong ( P > 0.05). The results show that the high-dose and low-dose groups of Wu Gu Chong can significantly reduce the level of estradiol hormone in rats with hyperplasia of mammary glands, and the efficacy is equivalent to that of the positive drugs.
对大鼠催乳素水平结果分析可知,与正常对照组相比,模型组催乳素水平显著升高( P<0.01),与模型组相比,其余各给药组催乳素水平显著降低( P<0.01),与阳性药组相比,五谷虫高、中、低剂量均无显著差异( P>0.1)。结果表明,五谷虫高剂量、中、低剂量可以显著降低乳腺增生大鼠催乳素激素水平,药效与阳性药相当。 Analysis of the results of rat prolactin levels showed that compared with the normal control group, the prolactin level of the model group was significantly increased ( P <0.01), and compared with the model group, the prolactin levels of the other administration groups were significantly reduced ( P < 0.01). Compared with the positive drug group, there was no significant difference in the high, medium and low doses of Wu Gu Chong ( P > 0.1). The results showed that the high-dose, medium-, and low-dose of Wu Gu Chong can significantly reduce the level of prolactin hormone in rats with hyperplasia of mammary glands, and the efficacy is equivalent to that of the positive drugs.
本发明通过苯甲酸雌二醇联合黄体酮建立乳腺增生大鼠模型,以临床用药乳癖消片为阳性药,观察五谷虫醇水双提物对乳腺增生大鼠乳头高度与直径,乳腺组织以及激素水平雌二醇与催乳素的影响。本实验分3个阶段,分别为乳腺增生造模前、造模后、灌胃给药后。The present invention establishes a rat model of mammary gland hyperplasia through estradiol benzoate combined with progesterone. The clinical drug Rupixiao tablet is used as a positive drug to observe the effect of the alcohol-water double extract of arachnids on the nipple height and diameter, mammary gland tissue and The effect of estradiol and prolactin on hormone levels. This experiment is divided into 3 stages, namely, before modeling of breast hyperplasia, after modeling, and after intragastric administration.
造模前,各组大鼠的初始体重无显著差异( P>0.05)。正常组大鼠在造模期间体重持续增长,经过30d造模后,与正常对照组相比,其余各造模雌性大鼠体重均显著降低( P<0.01),表明注射苯甲酸雌二醇与黄体酮雌激素会抑制SD雌性大鼠的生长,从外形观察其造模较成功。经过灌胃给药27d,与正常对照组相比,其余各组雌性大鼠体重均显著降低( P<0.01),与模型组相比,其余各给药组雌性大鼠体重均无显著差异( P>0.1),说明阳性药乳癖消片与五谷虫高、中、低剂量不能缓解由于外源高水平雌激素所引起的雌性大鼠生长抑制的现象。 Before modeling, the initial body weight of rats in each group had no significant difference ( P >0.05). The weight of rats in the normal group continued to increase during the modeling period. After 30 days of modeling, compared with the normal control group, the weight of the rest of the modeled female rats was significantly reduced ( P <0.01), indicating that the injection of estradiol benzoate and the Progesterone estrogen can inhibit the growth of SD female rats, and its modeling is more successful from the appearance observation. After intragastric administration for 27 days, compared with the normal control group, the body weight of the female rats in the other groups was significantly reduced ( P <0.01). Compared with the model group, there was no significant difference in the body weight of the female rats in the other treatment groups ( P >0.1), indicating that the high, medium and low doses of the positive drug Rupixiao Tablets and Wu Gu Chong can not alleviate the growth inhibition of female rats caused by exogenous high levels of estrogen.
对于乳头高度与直径,各组大鼠的初始乳头高度与直径无显著差异( P>0.1)。造模30d后,与空白对照组相比,其余各组乳头高度与直径显著增高( P<0.01),说明注射苯甲酸雌二醇与黄体酮雌激素会促进SD雌性大鼠乳头的生长。灌胃给药27d后,与正常对照组相比,模型组乳头直径显著增高( P<0.01),其余各给药组乳头高度显著下降( P<0.01);阳性药组、五谷虫高、中、低剂量之间无显著差异( P>0.05)。表明五谷虫可治疗由于外源雌激素水平增高所引起的乳头增大的现象。 Regarding the nipple height and diameter, the initial nipple height and diameter of rats in each group had no significant difference ( P >0.1). Thirty days after modeling, compared with the blank control group, the nipple height and diameter of the other groups were significantly increased ( P <0.01), indicating that injection of estradiol benzoate and progesterone estrogen can promote the growth of SD female rats' nipple. After 27 days of intragastric administration, compared with the normal control group, the nipple diameter of the model group was significantly increased ( P <0.01), and the nipple height of the other administration groups was significantly decreased ( P <0.01); the positive drug group, Wu Gu Chong high, medium There was no significant difference between the low doses ( P >0.05). It shows that Wu Gu Chong can treat the phenomenon of nipple enlargement caused by the increase of exogenous estrogen level.
雌激素过高会使子宫壁增厚,结果显示,与正常对照组相比,模型组子宫指数显著升高( P<0.01),与模型组相比,各给药组子宫指数显著下降( P<0.01);阳性药组、五谷虫高、中、低剂量之间无显著差异( P>0.05)。表明五谷虫可治疗由于外源雌激素水平增高所引起的子宫增厚的现象。 Excessive estrogen will thicken the uterine wall. The results show that compared with the normal control group, the uterine index of the model group was significantly increased ( P <0.01), and compared with the model group, the uterine index of each administration group was significantly decreased ( P <0.01); there was no significant difference between the positive drug group and the high, medium and low doses of Wu Gu Chong ( P > 0.05). It shows that Wu Gu Chong can treat the thickening of the uterus caused by the increase of exogenous estrogen levels.
下丘脑-垂体-性腺轴是神经结构组成部分之一,在维持内环境稳定和机体正常生理功能中扮演着重要角色 [14],性激素分泌异常会导致许多疾病的发生,如高催乳素血症、乳腺增生、子宫肌瘤等。各种性激素水平共同调控乳腺组织,其中催乳素 ( PRL) 水平升高被认为是引起乳腺增生的重要因素 [15,16],孕酮 ( PROG) 水平对腺泡组织和乳腺小叶起到促进作用,雌二醇 ( E 2 ) 水平增高对导管周围纤维组织和乳腺导管的生长起到抑制作用。性激素紊乱常发生于乳腺增生模型中,可通过调控下丘脑-垂体-性腺轴平衡来调节 E 2、PROG、PRL水平,恢复卵巢功能,消除小叶增生及腺泡增生 [5]。大鼠催乳素水平结果分析,我们知道与正常对照组相比,模型组催乳素水平显著升高( P<0.01),与模型组相比,其余各给药组催乳素水平显著降低( P<0.01),与阳性药组相比,五谷虫高、中、低剂量均无显著差异( P>0.1)。表明五谷虫高剂量、中、低剂量可以显著降低乳腺增生大鼠催乳素激素水平。对于雌二醇来讲,与正常对照组相比,模型组雌二醇水平显著升高( P<0.01),与模型组相比,其余各给药组雌二醇水平显著降低( P<0.01),与阳性药组相比,五谷虫中剂量组显著升高( P<0.05),五谷虫高剂量与低剂量无显著差异( P>0.05)。表明五谷虫高剂量、低剂量组可以显著降低乳腺增生大鼠雌二醇激素水平。 The hypothalamic-pituitary-gonadal axis is one of the components of the nerve structure and plays an important role in maintaining the stability of the internal environment and the normal physiological functions of the body [14] . Abnormal secretion of sex hormones can lead to many diseases, such as hyperprolactinemia. , Breast hyperplasia, uterine fibroids, etc. The levels of various sex hormones jointly regulate breast tissue, among which elevated levels of prolactin (PRL) are considered to be an important factor in causing breast hyperplasia [15,16] , and progesterone (PROG) levels promote acinar tissue and breast lobules , Estradiol (E 2 ) increased levels inhibited the growth of fibrous tissue around ducts and mammary ducts. Sex hormone disorders often occur in breast hyperplasia models, which can regulate the balance of the hypothalamus-pituitary-gonadal axis to regulate the levels of E 2 , PROG, and PRL, restore ovarian function, and eliminate lobular hyperplasia and acinar hyperplasia [5] . Analysis of the results of rat prolactin levels, we know that compared with the normal control group, the prolactin level of the model group was significantly increased ( P <0.01), compared with the model group, the prolactin levels of the other administration groups were significantly reduced ( P < 0.01). Compared with the positive drug group, there was no significant difference in the high, medium and low doses of Wu Gu Chong ( P > 0.1). It shows that the high dose, medium and low dose of Wu Gu Chong can significantly reduce the level of prolactin hormone in rats with hyperplasia of mammary glands. For estradiol, compared with the normal control group, the estradiol level of the model group was significantly increased ( P <0.01), and compared with the model group, the estradiol level of the other administration groups was significantly reduced ( P <0.01) ), compared with the positive drug group, the Wu Gu Chong medium dose group was significantly higher ( P <0.05), and there was no significant difference between the high and low doses of Wu Gu Chong ( P > 0.05). It shows that the high-dose and low-dose groups of Wu Gu Chong can significantly reduce the level of estradiol hormone in rats with hyperplasia of mammary glands.
综上所述,五谷虫能调节乳腺增生大鼠体内紊乱的激素,其主要成分具有平衡雌激素功能,对乳腺增生具有保护与修复作用。In summary, the worm can regulate the disordered hormones in rats with mammary gland hyperplasia, and its main components have the function of balancing estrogen, and have protective and repairing effects on mammary gland hyperplasia.
Claims (10)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010307600.8 | 2020-04-17 | ||
| CN202010307600.8A CN111297910B (en) | 2020-04-17 | 2020-04-17 | Application of five-cereal worms in preparation of medicaments for preventing and treating hyperplasia of mammary glands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2021208280A1 true WO2021208280A1 (en) | 2021-10-21 |
Family
ID=71146467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2020/102074 Ceased WO2021208280A1 (en) | 2020-04-17 | 2020-07-15 | Application of dried fly larva in preparation of drugs for preventing and treating breast hyperplasia |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN111297910B (en) |
| WO (1) | WO2021208280A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111297910B (en) * | 2020-04-17 | 2023-08-18 | 杭州益科堂生物科技有限公司 | Application of five-cereal worms in preparation of medicaments for preventing and treating hyperplasia of mammary glands |
| CN111617109B (en) * | 2020-06-11 | 2023-12-22 | 杭州益科堂生物科技有限公司 | Application of five-cereal insect medicament, five-cereal insect medicament and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106420826A (en) * | 2016-02-26 | 2017-02-22 | 浙江佰科堂生物科技股份有限公司 | Application of oriental latrine fly larvina product in preparing drugs, health care products or foods for treating lymphoma |
| CN110327374A (en) * | 2019-07-31 | 2019-10-15 | 浙江佰科堂生物科技股份有限公司 | A kind of pharmaceutical composition for being used to prevent and/or treat convulsions prepared with maggot |
| CN111297910A (en) * | 2020-04-17 | 2020-06-19 | 杭州益科堂生物科技有限公司 | Application of maggot in preparing medicine for preventing and treating hyperplasia of mammary glands |
-
2020
- 2020-04-17 CN CN202010307600.8A patent/CN111297910B/en active Active
- 2020-07-15 WO PCT/CN2020/102074 patent/WO2021208280A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106420826A (en) * | 2016-02-26 | 2017-02-22 | 浙江佰科堂生物科技股份有限公司 | Application of oriental latrine fly larvina product in preparing drugs, health care products or foods for treating lymphoma |
| CN110327374A (en) * | 2019-07-31 | 2019-10-15 | 浙江佰科堂生物科技股份有限公司 | A kind of pharmaceutical composition for being used to prevent and/or treat convulsions prepared with maggot |
| CN111297910A (en) * | 2020-04-17 | 2020-06-19 | 杭州益科堂生物科技有限公司 | Application of maggot in preparing medicine for preventing and treating hyperplasia of mammary glands |
Non-Patent Citations (2)
| Title |
|---|
| NIU JUN, CHENG XUANXUAN YANG QUAN CHEN ZEPENG HU XINJUN TANG XIAOMIN ZHENG RONGHAO PAN LIMING ZHANG CHUNRONG: "Review on Chinese Medicine Larva of Chrysomyia megacephala", MODERN CHINESE MEDICINE, ZHONG GUO XIAN DAI ZHONG YAO BIAN JI BU, CN, vol. 18, no. 10, 16 October 2016 (2016-10-16), CN , pages 1371 - 1375, XP055857213, ISSN: 1673-4890, DOI: 10.13313/j.issn.1673-4890.2016.10.029 * |
| WU, HAIFENG: "Mammary Gland Hyperplasia Medical Case 2", COMPOUND PRESCRIPTION FOR MAJOR DISEASES, 31 January 2015 (2015-01-31) * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111297910B (en) | 2023-08-18 |
| CN111297910A (en) | 2020-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021208280A1 (en) | Application of dried fly larva in preparation of drugs for preventing and treating breast hyperplasia | |
| WO2017101889A1 (en) | Formula, preparation method and use of chinese herbal medicine composition for soothing liver | |
| CN106176717A (en) | A kind of probucol lovastatin compound and preparation method | |
| CN104740536A (en) | Pharmaceutical composition for treating endometriosis (EMT) and adenomyosis (AM) and preparation method and use thereof | |
| WO2025066831A1 (en) | Use of cftr corrector in preparation of drug for treating hyperplasia of the mammary glands | |
| WO2020077819A1 (en) | Pharmaceutical use of anemoside b4 against acute gouty arthritis | |
| CN103599093A (en) | Novel anti-HPV (Human Papillomavirus) medicinal preparation and application | |
| CN101209263B (en) | Medicine for treating tumor | |
| CN113876834B (en) | Application of a kind of traditional Chinese medicine extract in the preparation of anti-mammary gland hyperplasia Chinese medicine product | |
| CN109303781A (en) | The application of tetramethylpyrazine in the preparation of medicine for the treatment of endometriosis | |
| CN103933475B (en) | A kind of pharmaceutical composition treating mammary gland fibroma and its production and use | |
| CN1403172A (en) | Medicine release controller for treating women's climacteric syndrome | |
| CN114848730B (en) | Preparation and application of a compound traditional Chinese medicine composition for treating acute plasma cell mastitis | |
| CN117338799A (en) | Application of geniposide in preparation of medicine for treating hyperplasia of mammary glands | |
| CN1660344A (en) | Combination of medication for treating disease of hyperplasia of mammary glands glands and preparation method | |
| CN115569177B (en) | Traditional Chinese medicine composition for treating plasma cell mastitis and its preparation method and use | |
| CN116036166B (en) | Traditional Chinese medicine composition for relieving breast distending pain and application thereof | |
| CN112755157B (en) | Liver-soothing and carbuncle-eliminating decoction compound for treating granulomatous mastitis in lump stage | |
| JP7462783B2 (en) | Medical Use of Anemoside B4 in the Treatment of Oral Ulcers | |
| CN102283834A (en) | Orlisat-containing medicinal composition and application thereof | |
| CN101804142B (en) | Traditional Chinese medicine composition for treating carcinoma of uterine body | |
| CN103860561B (en) | A kind of pharmaceutical composition and application thereof preventing and treating breast carcinoma | |
| CN118203578A (en) | Application of oxeridine in the preparation of drugs for preventing or treating perioperative hypothermia | |
| CN114533757A (en) | Application of micromolecular fucoidan in preparation of endometriosis drugs and health-care food | |
| CN103550442B (en) | External preparation for treating hyperplasia of mammary glands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20930964 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 20930964 Country of ref document: EP Kind code of ref document: A1 |